Dian Diagnostics' controlling shareholder pledges additional shares

Dian Diagnostics Group (SZSE:300244) announced that its controlling shareholder, Chen Haibin, has completed the pledge of 9 million shares, representing 5.47% of his holdings and 1.44% of the company's total share capital. The pledge, which runs from June 25, 2025, to June 27, 2026, is in favor of Yunnan International Trust Co., Ltd. While the purpose is to repay other debts, the company states the pledge will not impact business operations, governance, or control, and does not trigger performance compensation obligations. Following the pledge, Chen Haibin's total pledged shares amount to 98.76 million, or 60.06% of his holdings, representing 15.80% of Dian Diagnostic's total share capital. The company states it will continue to monitor the situation and fulfill disclosure requirements.